Published in

Precision Cancer Medicine, (3), p. 17-17, 2020

DOI: 10.21037/pcm-20-20

Precision Cancer Medicine, (3), p. 17-17, 2020

DOI: 10.21037/pcm-2020-potb-02

Links

Tools

Export citation

Search in Google Scholar

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO